A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP Inhibitor) in Subjects with Previously Unteated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  • Goss, Geraldine (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA Reference Number: HREC/15/HNE/440.
SSA Reference Number: SSA/16/MonH/111.
Monash Health HREC Ref: 16163X
Effective start/end date20/05/1919/05/24


  • clinical trial
  • treatment efficacy
  • phase 3 study
  • ovarian cancer
  • fallopian tube cancer